NCT00141817View on ClinicalTrials.gov

Study Evaluating Pantoprazole in Children With GERD

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Gastroesophageal Reflux

Interventions

DRUG

pantoprazole for approximately 9 weeks.

Trial Locations (23)

10032

New York

20010

Washington D.C.

32504

Pensacola

32610

Gainesville

33101

Miami

38105

Memphis

39216

Jackson

40202

Louisville

45229

Cincinnati

46202

Indianapolis

48201

Detroit

48503

Flint

53226

Milwaukee

60068

Park Ridge

64108

Kansas City

72205

Little Rock

76508

Temple

84108

Salt Lake City

92103

San Diego

92868

Orange

02114

Boston

02115

Boston

02302

Brockton

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00141817 - Study Evaluating Pantoprazole in Children With GERD | Biotech Hunter | Biotech Hunter